RRP12

RRP12-like protein · Q5JTH9 · RRP12 on Sugi Atlas →

0 patent compounds predicted against RRP12, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RRP12 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
P. Falciparum Resistance to Artemisinin in Vietnam PHASE4UNKNOWN
Effectiveness and Safety of Artesunate-Amodiaquine and Artemether-Lumefantrine for the Treatment of Malaria in Yaounde PHASE4COMPLETED
Management of Retinitis Pigmentosa Via Combination of Wharton's Jelly-derived Mesenchymal Stem Cells and Magnovision PHASE3COMPLETED
An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors PHASE1/PHASE2RECRUITING
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 PHASE2COMPLETED
Mobilization of Stem Cells With G-CSF for Collection From Patients With Diamond-Blackfan Anemia PHASE2COMPLETED
S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung Cancer PHASE2COMPLETED
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers PHASE2COMPLETED
Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP) PHASE1UNKNOWN
Safety of Peptide Vaccination for Patients With Myelodysplastic Syndrome PHASE1COMPLETED
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) PHASE1COMPLETED
Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Esophageal Cancer PHASE1COMPLETED
Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein PHASE1COMPLETED
Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome EARLY_PHASE1ACTIVE_NOT_RECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Inhibition of SENP1 for the Suppression of OS Growth and Metastasis nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Explore the Role of NLRP7 in the Regulation of Progestereone Induced Decidualization of Human Endometrial Stroma Cells nanCOMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
New Biomarkers for Diagnosis and Follow-up of Patients With LRBA or CTLA4 Deficiencies nanUNKNOWN
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
Studies on the Expression and Functions of RLIP76 in Blood Samples of Healthy Human Subjects nanWITHDRAWN
A Comparison of Rapid Immunoassay Tests for the Detection of Ruptured Membranes nanWITHDRAWN
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a RRP12 binder may also engage these)

ProteinNameSimilarity
Q5ZKD5 1.000 Q5ZKD5 →
Q6P5B0 0.998 Q6P5B0 →
Q8NDA8 0.984 Q8NDA8 →
Q86Y56 0.981 Q86Y56 →
E0CZ22 0.981 E0CZ22 →
E1BP36 0.980 E1BP36 →
TTI1 TELO2-interacting protein 1 homolog 0.979 landscape →
Q9GM44 0.979 Q9GM44 →
Q0V9L1 0.978 Q0V9L1 →
PDS5A Sister chromatid cohesion protein PDS5 homolog A 0.978 landscape →
MMS19 MMS19 nucleotide excision repair protein homolog 0.978 landscape →
Q6A026 0.978 Q6A026 →
F1R2X6 0.978 F1R2X6 →
A0JMW2 0.977 A0JMW2 →
Q6DCF2 0.977 Q6DCF2 →
Q9Y6B7 0.976 Q9Y6B7 →
Q9JLN9 0.976 Q9JLN9 →
Q9WV76 0.976 Q9WV76 →
F1MKX4 0.976 F1MKX4 →
A1L1F4 0.976 A1L1F4 →
Q9D071 0.976 Q9D071 →
Q8K2Z4 0.976 Q8K2Z4 →
A4L9P7 0.975 A4L9P7 →
Q91V83 0.975 Q91V83 →
MTOR Serine/threonine-protein kinase mTOR 0.975 landscape →
A2VE70 0.975 A2VE70 →
Q9ESJ4 0.974 Q9ESJ4 →
Q9UJ98 0.974 Q9UJ98 →
Q5F3V3 0.974 Q5F3V3 →
P42346 0.974 P42346 →